Syon Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
4,786
+173
+4% +$51.4K 0.07% 214
2025
Q4
$1.26M Buy
4,613
+362
+9% +$98.4K 0.06% 234
2025
Q3
$1.15M Buy
4,251
+273
+7% +$74.3K 0.06% 229
2025
Q2
$1.1M Buy
3,978
+180
+5% +$49K 0.07% 191
2025
Q1
$1.01M Buy
3,798
+543
+17% +$134K 0.08% 185
2024
Q4
$756K Buy
3,255
+954
+41% +$219K 0.07% 198
2024
Q3
$508K Sell
2,301
-635
-22% -$131K 0.04% 274
2024
Q2
$577K Sell
2,936
-187
-6% -$38.6K 0.05% 235
2024
Q1
$672K Sell
3,123
-849
-21% -$178K 0.06% 218
2023
Q4
$837K Buy
3,972
+2,144
+117% +$457K 0.04% 292
2023
Q3
$366K Buy
+1,828
New +$363K 0.05% 239

Other funds holding CME

Syon Capital's CME Position: Q1 2026 in Review

Syon Capital increased its CME Group (CME) stake by 3.8% in Q1 2026, buying an estimated $51.4K and bringing the position to 4,786 shares worth $1.41M. The position accounts for 0.07% of the portfolio, ranked #214.

Syon Capital first reported a position in CME in Q3 2023 and has held it in 11 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Syon Capital held 4,786 shares of CME Group worth $1.41M as of Q1 2026.
  • Syon Capital bought 173 CME Group shares in Q1 2026, an estimated $51.4K.
  • CME Group made up 0.07% of Syon Capital's portfolio in Q1 2026, its #214 holding.
  • Syon Capital first reported a position in CME Group in Q3 2023 and has held it in 11 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.